Sandra E. Wilkinson - Concepedia

Author

Sandra E. Wilkinson

Also Known As

S E Wilkinson, S Wilkinson, S. E. WILKINSON, S. E. Wilkinson, S. Wilkinson, S.E. Wilkinson, Sandra E Wilkinson, Sandra E. Wilkinson, Sandra Wilkinson

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Roche (United Kingdom)University College London Edinburgh Royal Infirmary

About

Sandra E. Wilkinson is an author at Roche (United Kingdom) specializing in medicine, cell signaling, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	2.2K
2	Natural Sciences	6	6	960
3	Biochemistry	5	5	896
4	Allergy	2	2	235
5	Health Sciences	1	1	22

Sandra E. Wilkinson

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C Sandra E. Wilkinson, Peter J. Parker, John Nixon Biochemical Journal Medicinal ChemistryBioorganic ChemistrySignal TransductionBiochemistryProtein Kinase C	1993	531
Potent selective inhibitors of protein kinase C Peter D. Davis, Christopher H. Hill, Elizabeth Keech, FEBS Letters InflammationCytokineMedicinal ChemistrySignal TransductionProtein Kinase C	1989	478
Phosphorylation of SLP-76 by the ZAP-70 Protein-tyrosine Kinase Is Required for T-cell Receptor Function Juliane Bubeck Wardenburg, Chong Fu, Janet Jackman, Journal of Biological Chemistry Signal TransductionCell RegulationSignaling PathwayG Protein-coupled ReceptorMedicine	1996	465
Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity Peter D. Davis, Lucy H. Elliott, William R. Harris, Journal of Medicinal Chemistry	1992	214
Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides Peter D. Davis, Christopher H. Hill, Geoffrey Lawton, Journal of Medicinal Chemistry Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryBioorganic ChemistryProtein Kinase C	1992	161
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction Rino A. Bit, Peter D. Davis, Lucy H. Elliott, Journal of Medicinal Chemistry Combinatorial ChemistryImmunologyMolecular BiologyPharmacotherapySelective Bisindolylmaleimides	1993	156
The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst Breda M. Twomey, Robert E. Muid, John Nixon, Biochemical and Biophysical Research Communications InflammationAllergyGranulocyteMedicineImmunology	1990	79
How has the ‘two‐week wait’ rule affected the presentation of colorectal cancer? Diya Pratish Chohan, K. Goodwin, Sandra E. Wilkinson, Colorectal Disease	2005	71
Fibroadenoma of the breast: A follow-up of conservative management Sandra E. Wilkinson, Thomas Anderson, Edith A. Rifkind, British journal of surgery Breast OncologySurgical PathologyHistopathologyPathologyClinical Diagnosis	1989	71
K252a is a potent and selective inhibitor of phosphorylase kinase Lucy H. Elliott, Sandra E. Wilkinson, Anthony D. Sedgwick, Biochemical and Biophysical Research Communications Molecular PharmacologySignal TransductionSignaling PathwayNatural SciencesMolecular Biology	1990	64

Page 1